HPV16/18 E5, a promising candidate for cervical cancer vaccines, affects SCPs, cell proliferation and cell cycle, and forms a potential network with E6 and E7

被引:16
|
作者
Liao, Shujie [1 ]
Deng, Dongrui [1 ]
Hu, Xiaoji [1 ]
Wang, Wei [1 ]
Li, Li [1 ]
Li, Wei [1 ]
Zhou, Jianfeng [1 ]
Xu, Gang [1 ]
Meng, Li [1 ]
Wang, Shixuan [1 ]
Ma, Ding [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430030, Hubei, Peoples R China
基金
美国国家科学基金会;
关键词
human papillomavirus; E5; cervical cancer; GENE-EXPRESSION; HPV-16; E5; PROTEIN; ONCOPROTEIN; PROGRESSION; INHIBITION; ADHESION; RECEPTOR;
D O I
10.3892/ijmm.2012.1168
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The spindle checkpoint proteins (SCPs), which sense the existence of misaligned sister chromatids during mitosis and meiosis, are essential for cell proliferation and differentiation. Therefore, the role of SCPs in carcinogenesis is gaining. increased attention. In this study, we analysed the expression of Bub1 and Mad2 in clinical samples by immunohistochemistry (IHC) during the development of cervical cancer (CC), and we explored the interaction of Bub1/Mad2 with different proteins through immunoprecipitation (IP). Furthermore, we analysed the characteristics of four different cell models of human papillomavirus (HPV)16/18 E5. We demonstrated that with the progression of CC, the expression of Bub1 and Mad2 was gradually reduced under the influence of HPVE5. Overexpression of HPV16/18 E5 significantly increased cell proliferation, as well as the percentage of cells in the S phase. In addition, the levels of p21, Bub1 and Mad2 were markedly decreased in E5-expressing cells. Therefore, HPV16/18 E5 plays a critical role in carcinogenesis and is a potential therapeutic target in CC treatment.
引用
收藏
页码:120 / 128
页数:9
相关论文
共 50 条
  • [1] Do or Die: HPV E5, E6 and E7 in Cell Death Evasion
    Skelin, Josipa
    Sabol, Ivan
    Tomaic, Vjekoslav
    PATHOGENS, 2022, 11 (09):
  • [2] THE CORRELATION BETWEEN HPV16 E6 AND E7 PROTEINS AND TELOMERASE EXPRESSION IN CERVICAL CANCER CARCINOGENESIS
    ZHANG, Y. U. N. B. O.
    JI, X. I. N. B. O.
    GU, S. H. E. N. H. O. N. G.
    WU, H. U. A. J. U. N.
    FU, B. I. W. E. I.
    ACTA MEDICA MEDITERRANEA, 2022, 38 (02): : 831 - 836
  • [3] HPV16 mutant E6/E7 construct is protective in mouse model
    Goodarzi, Maryam Moazami
    Mosayebi, Ghasem
    Ganji, Ali
    Raoufi, Ehsan
    Sadelaji, Samira
    Babaei, Saeid
    Abtahi, Hamid
    BMC BIOTECHNOLOGY, 2024, 24 (01)
  • [4] Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7
    Henken, F. E.
    Oosterhuis, K.
    Oehlschlaeger, P.
    Bosch, L.
    Hooijberg, E.
    Haanen, J. B. A. G.
    Steenbergen, R. D. M.
    VACCINE, 2012, 30 (28) : 4259 - 4266
  • [5] Establishment of immunoassay for detecting HPV16 E6 and E7 RNA
    Ding, Sen
    Qian, Steven Y.
    Zhang, Yang
    Wu, Wenlei
    Lu, Gensheng
    Lu, Yan
    Feng, Xiujing
    Li, Li
    Shen, Pingping
    SCIENTIFIC REPORTS, 2015, 5
  • [6] Development of HPV16,18,31,45 E5 and E7 peptides-based vaccines predicted by immunoinformatics tools
    Namvar, Ali
    Panahi, Heidar Ali
    Agi, Elnaz
    Bolhassani, Azam
    BIOTECHNOLOGY LETTERS, 2020, 42 (03) : 403 - 418
  • [7] New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
    K Yamato
    T Yamada
    M Kizaki
    K Ui-Tei
    Y Natori
    M Fujino
    T Nishihara
    Y Ikeda
    Y Nasu
    K Saigo
    M Yoshinouchi
    Cancer Gene Therapy, 2008, 15 : 140 - 153
  • [8] New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer
    Yamato, K.
    Yamada, T.
    Kizaki, M.
    Ui-Tei, K.
    Natori, Y.
    Fujino, M.
    Nishihara, T.
    Ikeda, Y.
    Nasu, Y.
    Saigo, K.
    Yoshinouchi, M.
    CANCER GENE THERAPY, 2008, 15 (03) : 140 - 153
  • [9] E6/E7 and E6*From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
    Artaza-Irigaray, Cristina
    Molina-Pineda, Andrea
    Aguilar-Lemarroy, Adriana
    Ortiz-Lazareno, Pablo
    Limon-Toledo, Laura P.
    Pereira-Suarez, Ana L.
    Rojo-Contreras, Wendoline
    Jave-Suarez, Luis F.
    FRONTIERS IN IMMUNOLOGY, 2019, 10 : 1676
  • [10] Induction of cell cycle arrest and apoptosis by 5-fluorouracil in laryngeal cancer cells containing HPV16 E6 and E7 oncoproteins
    Liu, Han Ching
    Chen, George G.
    Vlantis, Alexander C.
    Tong, Michael C. F.
    Chan, Paul K. S.
    van Hasselt, C. Andrew
    CLINICAL BIOCHEMISTRY, 2008, 41 (14-15) : 1117 - 1125